Management of Heart Failure in Italian Outpatients Clinics: Observational Study
OPTIMA-HF
Optimization of Therapy in the Italian Management of Heart Failure: OPTIMA-HF Observational Study
1 other identifier
observational
4,000
1 country
1
Brief Summary
OPTIMA-HF is an observational, cross-sectional, multicenter, real-life study conducted in two different clinical settings: HF outpatients' clinics of Italian University Hospitals and territorial Cardiology outpatients' services. Aim of the Optimization of Therapy in the Italian Management of Heart Failure \[OpTIMa-HF\] Registry is to collect data on HF patients followed in different Italian outpatients' settings to describe the current Italian population of HF patients, in terms of demographic characteristics and disease features, with a specific focus on guideline-directed medical therapy (GDMT) prescription, assessing its improvement after educational activities. In the present analysis we report the baseline data on the general enrolled population with a specific focus on HFrEF treatment adherence and prescription rates, according to the most recent European Guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 20, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFebruary 29, 2024
February 1, 2024
11 months
February 20, 2024
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
HF treatment adherence according to the most recent European Guidelines
Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.
12 months
Interventions
Data collection on heart failure therapy and follow up
Eligibility Criteria
HF patients in stable clinical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federico II University of Naples, Department of Advanced Biomedical Sciences
Napoli, 80131, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 20, 2024
First Posted
February 29, 2024
Study Start
March 1, 2023
Primary Completion
February 1, 2024
Study Completion
February 1, 2025
Last Updated
February 29, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share